ObjectiveTo explore parents’ perspectives, concerns and experiences of the management of lower respiratory tract infections (LRTIs) in children in primary care.DesignQualitative semistructured interview study.SettingUK primary care.Participants23 parents of children aged 6 months to 10 years presenting with LRTI in primary care.MethodThematic analysis of semistructured interviews (either in person or by telephone) conducted with parents to explore their experiences and views on their children being prescribed antibiotics for LRTI.ResultsFour major themes were identified and these are perspectives on: (1) infection, (2) antibiotic use, (3) the general practitioner (GP) appointment and (4) decision making around prescribing. Symptomatic relief was a key concern: the most troublesome symptoms were cough, breathing difficulty, fever and malaise. Many parents were reluctant to use self-care medication, tended to support antibiotic use and believed they are effective for symptoms, illness duration and for preventing complications. However, parental expectations varied from a desire for reassurance and advice to an explicit preference for an antibiotic prescription. These preferences were shaped by: (1) the age of the child, with younger children perceived as more vulnerable because of their greater difficulty in communicating, and concerns about rapid deterioration; (2) the perceived severity of the illness; and (3) disruption to daily routine. When there was disagreement with the GP, parents described feeling dismissed, and they were critical of inconsistent prescribing when they reconsult. When agreement between the parent and the doctor featured, parents described a feeling of relief and legitimation for consulting, feeling reassured that the illness did indeed warrant a doctor’s attention.ConclusionSymptomatic relief is a major concern for parents. Careful exploration of expectations, and eliciting worries about key symptoms and impact on daily life will be needed to help parents understand when a no antibiotic recommendation or delayed antibiotic recommendation is made.
Objectives To use illness severity scores to evaluate the appropriateness of antibiotic prescribing in UK general practice. Methods We describe variations in practice prescribing rates, taking account of illness severity. We used three scores in three studies to measure severity: ‘FeverPAIN’ in an adult acute sore throat cohort (n = 12 829), the ‘3C score’ in an adult acute lower respiratory tract infection cohort (n = 28 883) and the STARWAVe score in an acute cough and respiratory infection children’s cohort (n = 8394). We calculated median ORs to quantify practice-level variation in prescribing rates, adjusted for illness severity. Results There was substantial variability in practice prescribing rates (ranges of 0%–97%, 7%–100% and 0%–75% in the three cohorts, respectively). There was evidence that higher prescribing practices saw a higher proportion of unwell patients. At the individual level, patients who were more unwell were more likely to receive a prescription, but prescribing levels for those with low scores were still high. The median OR was 2.5 (95% credible interval = 2.2–2.9) in the sore throat data set, 2.9 (95% credible interval = 2.6–3.2) in the adult cough data set and 2.1 (95% credible interval = 1.8–2.4) in the children’s cough data set. Conclusions Higher prescribing practices may see more unwell patients with high illness severity scores, but the differences in scores account for a minority of between-practice prescribing variation. There is likely to be scope for further reductions in antibiotic prescribing among patients with low illness severity scores. Further research is needed to explore the additional factors that account for variation in prescribing levels.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.